Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: Exploratory analysis of real-world, multicenter data
Số trang: 9
Loại file: pdf
Dung lượng: 891.09 KB
Lượt xem: 7
Lượt tải: 0
Xem trước 1 trang đầu tiên của tài liệu này:
Thông tin tài liệu:
Despite the poor prognosis of triple-negative breast cancer (TNBC), it has been demonstrated that neoadjuvant immunotherapy in combination with chemotherapy can improve the pathologic complete response (pCR) rate and/or long-term outcome of TNBC. However, there have been no real-world studies reporting on the efectiveness of neoadjuvant checkpoint inhibitors in early TNBC.
Tìm kiếm theo từ khóa liên quan:
BMC Cancer Tripe-negative breast cancer Neoadjuvant immunotherapy Anti-PD-1/L1 antibody Real-world studyGợi ý tài liệu liên quan:
-
Differences between physician and patient preferences for cancer treatments: A systematic review
13 trang 169 0 0 -
6 trang 166 0 0
-
Immune checkpoint inhibitors and their impact on liver enzymes and attenuation
7 trang 139 0 0 -
2011–2021 rising prevalence of HPV infection among oropharyngeal carcinoma in France
9 trang 110 0 0 -
12 trang 87 0 0
-
19 trang 72 0 0
-
17 trang 60 0 0
-
9 trang 36 0 0
-
11 trang 35 0 0
-
12 trang 34 0 0